Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > Reality is top line data will do the talking - risks remain
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Mil_Man54on Feb 03, 2022 6:26pm
51 Views
Post# 34395271

RE:RE:Reality is top line data will do the talking - risks remain

RE:RE:Reality is top line data will do the talking - risks remain
Mil_Man54 wrote: Seems you left out a few things pumper such as the twiiter screenshots that our comments are based on...and here is my response to you attempt at clearing the CEO.ca board...

@Mil_Man54 @24KGold seems to be trying to clear the board of relevant posts by posting these small ones...but a couple things...you said nobody works for free but you have said you don't get paid for all the promotional work you do for FSD and ADon social media...so either you're an idiot or you're lying about not getting compensated...next...if Lucid has been working on this for 10 yrs, why didn't Pfizer scoop them up if their research was so promising...it telling that a twice failed company like FSD with its track record and legal troubles was able to acquire Lucid through granting of shares....everything else you're posting is nonsense and just there to clear the board as I said...typical pumper move just like you do on the Stockhouse board


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities